Clik here to view.
Boston Scientific gets in on $10m Series C round for thermal body mapper...
Boston Scientific (NYSE:BSX) joined a $10 million Series C round for Securus Medical Group, developer of a recently FDA-cleared thermal body mapping device. Proceeds from the round are slated to be...
View ArticleClik here to view.
French private equity players Ardian, Azulis Capital take majority stake in...
French private equity groups Ardian and Azulis Capital said today they inked an exclusive deal to buy a majority stake in orthopedics device maker Lagarrigue Group. France-based Lagarrigue designs and...
View ArticleClik here to view.
Intarcia raises another $215m to support its ITCA 650 drug pump
Intarcia Therapeutics said today it raised $215 million in a new round of financing to support the approval and launch of its ITCA 650 implantable drug pump, designed for treating type 2 diabetes,...
View ArticleClik here to view.
Misonix delays annual report, taps Dwyer as interim CFO
Misonix (NSDQ:MSON) said today it delayed its annual report due to “deficiencies” in its internal control over financial reporting, and that it tapped Joseph Dwyer as its interim CFO. The Farmingdale,...
View ArticleClik here to view.
3D printer Carbon raises $81m
Silicon Valley 3D printing company Carbon said today it raised $81 million in a new round of funding, looking to use funds to support its medical device and auto part printing service. Get the full...
View ArticleClik here to view.
Surgical robotics herald the super-surgeon
by Alistair Fleming, VP Medical, Sagentia Whilst in many industries the advance of robotics has created worries about robots supplanting humans, in the world of surgery, the next generation of robotics...
View ArticleClik here to view.
Progenerative Medical licenses KCI’s tissue regeneration tech
Progenerative Medical said this week that it inked an exclusive licensing agreement with Acelity subsidiary Kinetic Concepts Inc. for a negative-pressure technology portfolio it aims to develop for...
View ArticleClik here to view.
Minnesota doc creates $50 EpiPen alternative
A Minnesota doctor reportedly created a $50 EpiPen alternative and is trying to raise money to bring it to patients. Dr. Douglas McMahon, who has severe food allergies, told CBS Minnesota that he was...
View ArticleClik here to view.
Ex-HHS chief Sebelius joins Solera Health board
Solera Health said today that former U.S. Health & Human Services Dept. head Kathleen Sebelius joined its health advisory board. The Phoenix-based technology platform is designed to unite patients...
View ArticleClik here to view.
Varian wins FDA clearance for Nexus DR digital X-ray
Varian Medical (NYSE:VAR) said yesterday that it won 510(k) clearance from the FDA for its Nexus DR digital X-ray system. The Palo Alto-based company markets the device as a single common imaging...
View ArticleClik here to view.
Sofregen lands $6.2m Series A
Sofregen Medical said yesterday that it landed a $6.2 million Series A round from Polaris Partners and other founding investors, bringing their total funding raised to more than $11 million. The...
View ArticleClik here to view.
Shockwave Medical wins FDA clearance for peripheral vessel Lithoplasty device
Shockwave Medical said today that it won 510(k) clearance from the FDA for its Lithoplasty system, which is designed to treat calcified plaque in patients with peripheral artery disease. The Fremont,...
View ArticleClik here to view.
Hamilton Thorne picks up Embryotech Labs for $7m
Laser device and imaging analysis maker Hamilton Thorne said today it picked up Mass.-based Embryotech Laboratories for $7.25 million. Get the full story at our sister site, Medical Design &...
View ArticleClik here to view.
OptiNose touts Phase III data for exhaled breath drug delivery
OptiNose touted data from a pair of Phase III clinical trials proving the safety and efficacy of its exhaled breath drug delivery treatment for chronic rhinosinusitis patients with and without polyps....
View ArticleClik here to view.
Acclarent wins FDA nod for Aera Eustachian tube balloon
Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent said today that it won de novo clearance from the FDA for its Aera Eustachian tube balloon dilation system, designed to treat persistent Eustachian...
View ArticleClik here to view.
HHS, FDA finalize reporting rules for ClinicalTrials.gov
The U.S. Department of Health and Human Services and the FDA today released a final rule on results-reporting requirements for ClinicalTrials.gov, expanding registration requirements and providing a...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Johnson & Johnson to buy Abbot optics biz for $4.3B
Johnson & Johnson (NYSE:JNJ) said today it inked a deal to pick up Abbott‘s (NYSE:ABT) Medical Optics business for $4.3 billion in cash. The deal includes Abbott’s subsidiary Abbot Medical Optics,...
View ArticleClik here to view.
Agilent prices $300m notes offering
Agilent Technologies (NYSE:A) today released pricing for a $300 million public offering of senior notes, with proceeds slated to repay its revolving credit facility. The Santa Clara, Calif.-based...
View ArticleClik here to view.
Med-El USA wins FDA nod for Synchrony EAS hearing implant
Med-El USA said today it won FDA premarket approval for its Synchrony electric acoustic stimulation hearing implant system. The Synchrony EAS uses both the Synchrony cochlear implant designed to...
View Article